{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,18]],"date-time":"2025-11-18T01:36:59Z","timestamp":1763429819066,"version":"3.40.5"},"reference-count":43,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,5,20]],"date-time":"2022-05-20T00:00:00Z","timestamp":1653004800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.es","elsevier.es","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neurolog\u00eda"],"published-print":{"date-parts":[[2024,11]]},"DOI":"10.1016\/j.nrl.2022.04.010","type":"journal-article","created":{"date-parts":[[2022,5,23]],"date-time":"2022-05-23T08:26:57Z","timestamp":1653294417000},"page":"721-732","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"title":["S\u00edndrome de trombosis con trombocitopenia asociado a vacunas de adenovirus frente a la COVID-19: Epidemiolog\u00eda y presentaci\u00f3n cl\u00ednica de la serie espa\u00f1ola"],"prefix":"10.1016","volume":"39","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3132-1064","authenticated-orcid":false,"given":"D.","family":"Garc\u00eda-Azor\u00edn","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E.","family":"L\u00e1zaro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9226-4550","authenticated-orcid":false,"given":"D.","family":"Ezpeleta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R.","family":"Lecumberri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R.","family":"de la C\u00e1mara","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3116-1352","authenticated-orcid":false,"given":"M.","family":"Castellanos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3746-3001","authenticated-orcid":false,"given":"C.","family":"I\u00f1iguez Mart\u00ednez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L.","family":"Quiroga-Gonz\u00e1lez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G.","family":"Elizondo Rivas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Sancho-L\u00f3pez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P.","family":"Ray\u00f3n Iglesias","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E.","family":"Segovia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.","family":"Mej\u00edas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D.","family":"Montero Corominas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.nrl.2022.04.010_bib0220","unstructured":"Grupo de Trabajo T\u00e9cnico de Vacunaci\u00f3n COVID-19, de la Ponencia de Programa y Registro de Vacunaciones. Estrategia de vacunaci\u00f3n frente a COVID- 19 en Espa\u00f1a. Versi\u00f3n 1, 2 de diciembre 2020. [Consultado 15 Oct 2021]. Disponible en: https:\/\/www.mscbs.gob.es\/profesionales\/saludPublica\/prevPromocion\/vacunaciones\/covid19\/docs\/COVID-19_EstrategiaVacunacion.pdf"},{"key":"10.1016\/j.nrl.2022.04.010_bib0225","unstructured":"Divisi\u00f3n de Farmacoepidemiolog\u00eda y Farmacovigilancia. Agencia Espa\u00f1ola del Medicamento y Productos Sanitarios. Vigilancia de la Seguridad de las vacunas frente a la COVID-19, Versi\u00f3n 7, 25 de enero de 2021. [Consultado 15 Oct 2021]. Disponible en: https:\/\/www.aemps.gob.es\/medicamentosUsoHumano\/vacunas\/docs\/vigilancia_seguridad_vacunas_COVID-19.pdf?x11028"},{"key":"10.1016\/j.nrl.2022.04.010_bib0230","unstructured":"European Medicines Agency. 29 March 2021 update. COVID-19 vaccine safety update VAXZEVRIA AstraZeneca AB. [Consultado 22 Abril 2021]. Disponible en: https:\/\/www.ema.europa.eu\/en\/documents\/covid-19-vaccine-safety-update\/covid-19-vaccine-safety-update-vaxzevria-previously-covid-19-vaccine-astrazeneca-29-march-2021_en.pdf"},{"key":"10.1016\/j.nrl.2022.04.010_bib0235","doi-asserted-by":"crossref","first-page":"2124","DOI":"10.1056\/NEJMoa2104882","article-title":"Thrombosis and Thrombocytopenia after ChAdOx1 nCoV-19 vaccination","volume":"384","author":"Schultz","year":"2021","journal-title":"N Engl J Med."},{"key":"10.1016\/j.nrl.2022.04.010_bib0240","doi-asserted-by":"crossref","first-page":"2092","DOI":"10.1056\/NEJMoa2104840","article-title":"Thrombotic Thrombocytopenia after ChAdOx1 nCov-19 Vaccination","volume":"384","author":"Greinacher","year":"2021","journal-title":"N Engl J Med."},{"key":"10.1016\/j.nrl.2022.04.010_bib0245","first-page":"451","article-title":"Diagnostic, treatment recommendations from the, FACME., ad-hoc expert working group on the management of cerebral venous sinus thrombosis associated with COVID-19 vaccination","volume":"36","year":"2021","journal-title":"Neurologia (Engl Ed)"},{"key":"10.1016\/j.nrl.2022.04.010_bib0250","doi-asserted-by":"crossref","first-page":"2202","DOI":"10.1056\/NEJMoa2105385","article-title":"Pathologic Antibodies to Platelet Factor 4 after ChAdOx1 nCoV-19 Vaccination","volume":"384","author":"Scully","year":"2021","journal-title":"N Engl J Med."},{"key":"10.1016\/j.nrl.2022.04.010_bib0255","doi-asserted-by":"crossref","first-page":"1599","DOI":"10.3390\/jcm10081599","article-title":"Thrombocytopenia and Intracranial Venous Sinus Thrombosis after \u00abCOVID-19 Vaccine AstraZeneca\u00bb Exposure","volume":"10","author":"Wolf","year":"2021","journal-title":"J Clin Med."},{"key":"10.1016\/j.nrl.2022.04.010_bib0260","doi-asserted-by":"crossref","first-page":"117532","DOI":"10.1016\/j.jns.2021.117532","article-title":"Clinical review of cerebral venous thrombosis in the context of COVID-19 vaccinations: Evaluation, management, and scientific questions","volume":"427","author":"Thakur","year":"2021","journal-title":"J Neurol Sci."},{"key":"10.1016\/j.nrl.2022.04.010_bib0265","doi-asserted-by":"crossref","first-page":"2448","DOI":"10.1001\/jama.2021.7517","article-title":"US case reports of cerebral venous sinus thrombosis with thrombocytopenia after Ad26.COV2.S vaccination March 2 to April 21, 2021","volume":"325","author":"See","year":"2021","journal-title":"JAMA."},{"key":"10.1016\/j.nrl.2022.04.010_bib0270","unstructured":"European Medicines Agency.14 April 2021 update. COVID-19 vaccine safety update VAXZEVRIA AstraZeneca AB. [Consultado Abril 2021]. Disponible en: https:\/\/www.ema.europa.eu\/en\/documents\/covid-19-vaccine-safety-update\/covid-19-vaccine-safety-update-vaxzevria-previously-covid-19-vaccine-astrazeneca-14-april-2021_en.pdf"},{"key":"10.1016\/j.nrl.2022.04.010_bib0275","unstructured":"Agencia Espa\u00f1ola de Medicamentos y Productos Sanitarios. Nota de seguridad 1, 7 de abril de 2021. Vaxzevria (vacuna frente a la COVID-19 de AstraZeneca): actualizaci\u00f3n sobre el riesgo de trombosis. [Consultado 15 Oct. 2021]. Disponible en: https:\/\/www.aemps.gob.es\/informa\/notasInformativas\/medicamentosUsoHumano\/seguridad\/2021\/docs\/NI_MUH_FV-04-2021-AZ-actualizacion.pdf?x11028"},{"key":"10.1016\/j.nrl.2022.04.010_bib0280","unstructured":"Grupo de Trabajo T\u00e9cnico de Vacunaci\u00f3n COVID-19, de la Ponencia de Programa y Registro de Vacunaciones. Estrategia de vacunaci\u00f3n frente a COVID- 19 en Espa\u00f1a. Actualizaci\u00f3n 6, 20 de abril de 2021. [Consultado 15 Oct. 2021]. Disponible en: https:\/\/www.mscbs.gob.es\/profesionales\/saludPublica\/prevPromocion\/vacunaciones\/covid19\/docs\/COVID-19_Actualizacion6_EstrategiaVacunacion.pdf"},{"key":"10.1016\/j.nrl.2022.04.010_bib0285","doi-asserted-by":"crossref","first-page":"e297","DOI":"10.1371\/journal.pmed.0040297","article-title":"STROBE Initiative. Strengthening the Reporting of Observational Studies in Epidemiology (STROBE): explanation and elaboration","volume":"4","author":"Vandenbroucke","year":"2007","journal-title":"PLoS Med."},{"key":"10.1016\/j.nrl.2022.04.010_bib0290","unstructured":"World Health Organization. Guidance document for clinical case management of thrombosis with thrombocytopenia syndrome (TTS) following coronavirus disease (COVID-19) vaccination. Interim guidance 1 July 2021. [Consultado 15 Oct. 2021]. Disponible en: https:\/\/apps.who.int\/iris\/bitstream\/handle\/10665\/342999\/WHO-2019-nCoV-TTS-2021.1-eng.pdf"},{"key":"10.1016\/j.nrl.2022.04.010_bib0295","unstructured":"Registro de Vacunaci\u00f3n (REGVACU) del Ministerio de Sanidad. [Consultado 15 Oct. 2021]. Disponible en: https:\/\/www.mscbs.gob.es\/profesionales\/saludPublica\/ccayes\/alertasActual\/nCov\/vacunaCovid19.htm"},{"key":"10.1016\/j.nrl.2022.04.010_bib0300","first-page":"215","article-title":"Pharmacoepidemiological considerations in observed-to-expected analyses for vaccines. Pharmacoepidemiol","volume":"25","author":"Mahaux","year":"2016","journal-title":"Drug Saf."},{"key":"10.1016\/j.nrl.2022.04.010_bib0305","unstructured":"Fundaci\u00f3n para el Fomento de la Investigaci\u00f3n Sanitaria y Biom\u00e9dica de la Comunitat Valenciana (Fisabio) [Consultado 15 Oct. 2021]. Disponible en: http:\/\/fisabio.san.gva.es\/datos-basicos"},{"key":"10.1016\/j.nrl.2022.04.010_bib0310","doi-asserted-by":"crossref","first-page":"2554","DOI":"10.1111\/jth.15493","article-title":"Comparison of adverse drug reactions among four COVID-19 vaccines in Europe using the EudraVigilance database: Thrombosis at unusual sites","volume":"19","author":"Abbattista","year":"2021","journal-title":"J Thromb Haemost."},{"key":"10.1016\/j.nrl.2022.04.010_bib0315","doi-asserted-by":"crossref","first-page":"102685","DOI":"10.1016\/j.jaut.2021.102685","article-title":"Blood clots and bleeding events following BNT162b2 and ChAdOx1 nCoV-19 vaccine: An analysis of European data","volume":"122","author":"Cari","year":"2021","journal-title":"J Autoimmun."},{"key":"10.1016\/j.nrl.2022.04.010_bib0320","doi-asserted-by":"crossref","first-page":"e197","DOI":"10.3346\/jkms.2021.36.e197","article-title":"Predicted and Observed Incidence of Thromboembolic Events among Koreans Vaccinated with ChAdOx1 nCoV-19 Vaccine","volume":"36","author":"Huh","year":"2021","journal-title":"J Korean Med Sci."},{"key":"10.1016\/j.nrl.2022.04.010_bib0325","doi-asserted-by":"crossref","first-page":"101061","DOI":"10.1016\/j.eclinm.2021.101061","article-title":"Cerebral venous thrombosis and portal vein thrombosis: A retrospective cohort study of 537,913 COVID-19 cases","volume":"39","author":"Taquet","year":"2021","journal-title":"EClinicalMedicine."},{"key":"10.1016\/j.nrl.2022.04.010_bib0330","doi-asserted-by":"crossref","first-page":"n1114","DOI":"10.1136\/bmj.n1114","article-title":"Arterial events, venous thromboembolism, thrombocytopenia and bleeding after vaccination with Oxford-AstraZeneca ChAdOx1-S in Denmark and Norway: population based cohort study","volume":"373","author":"Pottegard","year":"2021","journal-title":"BMJ."},{"key":"10.1016\/j.nrl.2022.04.010_bib0335","doi-asserted-by":"crossref","first-page":"3656","DOI":"10.1111\/ene.15029","article-title":"Post-SARS-CoV-2-vaccination cerebral venous sinus thrombosis: an analysis of cases notified to the European Medicines Agency","volume":"28","author":"Krzywicka","year":"2021","journal-title":"Eur J Neurol."},{"key":"10.1016\/j.nrl.2022.04.010_bib0340","unstructured":"Medicines & Healthcare products Regulatory Agency. Coronavirus vaccine-weekly summary of Yellow Card reporting. Updated 2 December 2021. [Consultado 3 Dic. 2021]. Disponible en: https:\/\/www.gov.uk\/government\/publications\/coronavirus-covid-19-vaccine-adverse-reactions\/coronavirus-vaccine-summary-of-yellow-card-reporting"},{"issue":"10300","key":"10.1016\/j.nrl.2022.04.010_bib0345","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1016\/S0140-6736(21)01693-7","article-title":"Very rare thrombosis with thrombocytopenia after second AZD1222 dose: a global safety database analysis","volume":"398","author":"Bhuyan","year":"2021","journal-title":"Lancet."},{"key":"10.1016\/j.nrl.2022.04.010_bib0350","doi-asserted-by":"crossref","first-page":"1815","DOI":"10.1056\/NEJMc2112760","article-title":"Decline in Pathogenic Antibodies over Time in VITT","volume":"385","author":"Sch\u00f6nborn","year":"2021","journal-title":"N Engl J Med."},{"key":"10.1016\/j.nrl.2022.04.010_bib0355","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1056\/NEJMc2118507","article-title":"VITT and second doses of Covid-19 vaccine","volume":"386","author":"Lacy","year":"2022","journal-title":"N Eng J Med."},{"key":"10.1016\/j.nrl.2022.04.010_bib0360","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1186\/s10194-021-01324-5","article-title":"Delayed headache after COVID-19 vaccination: a red flag for vaccine induced cerebral venous thrombosis","volume":"22","author":"Garc\u00eda-Azor\u00edn","year":"2021","journal-title":"J Headache Pain."},{"key":"10.1016\/j.nrl.2022.04.010_bib0365","doi-asserted-by":"crossref","first-page":"1680","DOI":"10.1056\/NEJMoa2109908","article-title":"Clinical features of vaccine-induced thrombocytopenia and thrombosis","volume":"385","author":"Pavord","year":"2021","journal-title":"N Engl J Med."},{"issue":"10269","key":"10.1016\/j.nrl.2022.04.010_bib0370","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/S0140-6736(20)32661-1","article-title":"Oxford COVID Vaccine Trial Group. Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomised controlled trials in Brazil. South Africa, and the UK","volume":"397","author":"Voysey","year":"2021","journal-title":"Lancet."},{"key":"10.1016\/j.nrl.2022.04.010_bib0375","doi-asserted-by":"crossref","first-page":"950","DOI":"10.3390\/vaccines9090950","article-title":"Qualitative Assessment of Early Adverse Effects of Pfizer-BioNTech and Sinopharm COVID-19 Vaccines by Telephone Interviews","volume":"9","author":"Abu-Halaweh","year":"2021","journal-title":"Vaccines (Basel)."},{"key":"10.1016\/j.nrl.2022.04.010_bib0380","doi-asserted-by":"crossref","first-page":"46","DOI":"10.15585\/mmwr.mm7002e1","article-title":"Allergic Reactions Including Anaphylaxis After Receipt of the First Dose of Pfizer-BioNTech COVID-19 Vaccine - United States, December 14-23, 2020","volume":"70","year":"2021","journal-title":"MMWR Morb Mortal Wkly Rep."},{"key":"10.1016\/j.nrl.2022.04.010_bib0385","doi-asserted-by":"crossref","first-page":"1622","DOI":"10.1055\/a-1535-9002","article-title":"PF4-Dependent Immunoassays in Patients with Vaccine-Induced Immune Thrombotic Thrombocytopenia: Results of an Interlaboratory Comparison","volume":"121","author":"Sachs","year":"2021","journal-title":"Thromb Haemost."},{"key":"10.1016\/j.nrl.2022.04.010_bib0390","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1111\/jth.15572","article-title":"Vaccine-induced immune thrombotic thrombocytopenia (VITT): Update on diagnosis and management considering different resources","volume":"20","author":"Greinacher","year":"2021","journal-title":"J Thromb Haemost."},{"key":"10.1016\/j.nrl.2022.04.010_bib0395","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/j.thromres.2021.09.017","article-title":"Long-term follow-up after successful treatment of vaccine-induced prothrombotic immune thrombocytopenia","volume":"207","author":"Thaler","year":"2021","journal-title":"Thromb Res."},{"key":"10.1016\/j.nrl.2022.04.010_bib0400","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1111\/ene.15113","article-title":"Declining mortality of cerebral venous sinus thrombosis with thrombocytopenia after SARS-CoV-2 vaccination","volume":"29","author":"van de Munckhof","year":"2021","journal-title":"Eur J Neurol."},{"key":"10.1016\/j.nrl.2022.04.010_bib0405","doi-asserted-by":"crossref","first-page":"2103","DOI":"10.1056\/NEJMc2112974","article-title":"Vaccine-Induced Thrombocytopenia with Severe Headache","volume":"385","author":"Salih","year":"2021","journal-title":"N Engl J Med."},{"key":"10.1016\/j.nrl.2022.04.010_bib0410","doi-asserted-by":"crossref","first-page":"4662","DOI":"10.1182\/bloodadvances.2021005388","article-title":"VITT following Ad26.COV2.S vaccination presenting without radiographically demonstrable thrombosis","volume":"5","author":"Kennedy","year":"2021","journal-title":"Blood Adv."},{"key":"10.1016\/j.nrl.2022.04.010_bib0415","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1111\/bjh.17613","article-title":"Vaccine-induced immune thrombotic thrombocytopenia (VITT) - a novel clinico-pathological entity with heterogeneous clinical presentations","volume":"195","author":"Lavin","year":"2021","journal-title":"Br J Haematol."},{"key":"10.1016\/j.nrl.2022.04.010_bib0420","doi-asserted-by":"crossref","first-page":"e245440","DOI":"10.1136\/bcr-2021-245440","article-title":"Haematuria, a widespread petechial rash, and headaches following the Oxford AstraZeneca ChAdOx1 nCoV-19 Vaccination","volume":"14","author":"Waraich","year":"2021","journal-title":"BMJ Case Rep."},{"key":"10.1016\/j.nrl.2022.04.010_bib0425","doi-asserted-by":"crossref","first-page":"4053","DOI":"10.1093\/eurheartj\/ehab592","article-title":"Predictors of mortality in thrombotic thrombocytopenia after adenoviral COVID-19 vaccination: the FAPIC score","volume":"42","author":"Hwang","year":"2021","journal-title":"Eur Heart J."},{"key":"10.1016\/j.nrl.2022.04.010_bib0430","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1038\/s41586-021-03744-4","article-title":"Antibody epitopes in vaccine-induced immune thrombotic thrombocytopaenia","volume":"596","author":"Huynh","year":"2021","journal-title":"Nature."}],"container-title":["Neurolog\u00eda"],"original-title":[],"language":"es","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0213485322000676?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0213485322000676?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,11,13]],"date-time":"2024-11-13T22:25:36Z","timestamp":1731536736000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0213485322000676"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11]]},"references-count":43,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2024,11]]}},"alternative-id":["S0213485322000676"],"URL":"https:\/\/doi.org\/10.1016\/j.nrl.2022.04.010","relation":{},"ISSN":["0213-4853"],"issn-type":[{"type":"print","value":"0213-4853"}],"subject":[],"published":{"date-parts":[[2024,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"S\u00edndrome de trombosis con trombocitopenia asociado a vacunas de adenovirus frente a la COVID-19: Epidemiolog\u00eda y presentaci\u00f3n cl\u00ednica de la serie espa\u00f1ola","name":"articletitle","label":"Article Title"},{"value":"Neurolog\u00eda","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.nrl.2022.04.010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Sociedad Espa\u00f1ola de Neurolog\u00eda. Published by Elsevier Espa\u00f1a, S.L.U.","name":"copyright","label":"Copyright"}]}}